CRBU
Caribou Biosciences·NASDAQ
--
--(--)
--
--(--)
CRBU fundamentals
Caribou Biosciences (CRBU) Revenue Breakdown: Q3 2025 Business & Regional Performance
Caribou Biosciences (CRBU) reported total revenue of 2.20M USD in Q3 2025, with its core business segment Pfizer, Inc contributing 28.30%. Regionally, United States remained the largest market, accounting for 82.85% of total revenue. Explore Caribou Biosciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Caribou Biosciences (CRBU) reported total revenue of 2.20M USD in Q3 2025, with its core business segment Pfizer, Inc contributing 28.30%. Regionally, United States remained the largest market, accounting for 82.85% of total revenue. Explore Caribou Biosciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Caribou Biosciences's management provide for the next earnings period?What were the key takeaways from Caribou Biosciences’s earnings call?What is Caribou Biosciences's latest dividend and current dividend yield?Did Caribou Biosciences beat or miss consensus estimates last quarter?What is Caribou Biosciences's gross profit margin?What does Caribou Biosciences do and what are its main business segments?What is the market's earnings forecast for Caribou Biosciences next quarter?What were the key takeaways from Caribou Biosciences's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
